✦ LIBER ✦

Preliminary Treatment Patterns and Safety Outcomes for Non—Small-Cell Lung Cancer from ARIES, a Bevacizumab Treatment Observational Cohort Study

✍ Scribed by David Spigel; Priya Kumar; Siew Leng Teng; Lisa Wang; Willis Navarro; Thomas Lynch

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

9073 POSTER Clinical Outcomes for Bevaci

✍ Wozniak, A.; Kosty, M.R.; Jahanzeb, M.; Garst, J.; Spigel, D.; Leon, L.; Fish, S 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Treatment Patterns and Clinical Outcomes

✍ Bendell, J. C.; Bekaii-Saab, T. S.; Cohn, A. L.; Hurwitz, H. I.; Kozloff, M.; Te 📂 Article 📅 2012 🏛 Alphamed Press 🌐 English ⚖ 495 KB

9006 Safety of bevacizumab (BV) combined

✍ Jahanzeb, M.; Fischbach, N.; Kosty, M.; Kumar, P.; Spigel, D.; Wozniak, A.; Teng 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Safety and Effectiveness of Bevacizumab

✍ Hurwitz, H.I.; Bekaii-Saab, T.S.; Bendell, J.C.; Cohn, A.L.; Kozloff, M.; Roach, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 495 KB

9057 POSTER Clinical Management and Trea

✍ Cruciani, G.; Vergnenégre, A.; Thomas, M.; Blasco-Colmenares, E.; Medina, J.; Ca 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 44 KB

A phase II study of bevacizumab and erlo

✍ Akerley, Wallace; Boucher, Kenneth; Rich, Nathan; Egbert, Lyle; Harker, Graydon; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 282 KB